{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 239750, "items": [{"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T03:51:28Z", "timestamp": 1574135488349}, "reference-count": 12, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "3", "license": [{"URL": "http://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2004, 3, 1]], "date-time": "2004-03-01T00:00:00Z", "timestamp": 1078099200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Urology"], "published-print": {"date-parts": [[2004, 3]]}, "DOI": "10.1097/01.ju.0000112918.74410.94", "type": "journal-article", "created": {"date-parts": [[2004, 8, 25]], "date-time": "2004-08-25T22:26:49Z", "timestamp": 1093472809000}, "page": "1194-1198", "source": "Crossref", "is-referenced-by-count": 42, "title": ["Sustained Decrease in Incidence of Acute Urinary Retention and Surgery With Finasteride for 6 Years in Men With Benign Prostatic Hyperplasia"], "prefix": "10.1097", "volume": "171", "author": [{"given": "CLAUS G.", "family": "ROEHRBORN", "sequence": "first", "affiliation": [{"name": "From The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas (CGR, JDM), Clinical Science Center, University of Wisconsin, (RB) and Jackson Foundation (GHM), Madison, Wisconsin, Harvard Medical School, Boston, Massachusetts (BS), South Florida Medical Research, Aventura, Florida (MCG), Seattle, Washington (JEG), Merck Research Laboratories, Rahway, New Jersey (SS, JD, AM, JW) and Department of Urology, Queen\u2019s University, Kingston General Hospital, Ontario, Canada (JCN)"}]}, {"given": "REGINALD", "family": "BRUSKEWITZ", "sequence": "additional", "affiliation": [{"name": "From The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas (CGR, JDM), Clinical Science Center, University of Wisconsin, (RB) and Jackson Foundation (GHM), Madison, Wisconsin, Harvard Medical School, Boston, Massachusetts (BS), South Florida Medical Research, Aventura, Florida (MCG), Seattle, Washington (JEG), Merck Research Laboratories, Rahway, New Jersey (SS, JD, AM, JW) and Department of Urology, Queen\u2019s University, Kingston General Hospital, Ontario, Canada (JCN)"}]}, {"given": "J. CURTIS", "family": "NICKEL", "sequence": "additional", "affiliation": [{"name": "From The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas (CGR, JDM), Clinical Science Center, University of Wisconsin, (RB) and Jackson Foundation (GHM), Madison, Wisconsin, Harvard Medical School, Boston, Massachusetts (BS), South Florida Medical Research, Aventura, Florida (MCG), Seattle, Washington (JEG), Merck Research Laboratories, Rahway, New Jersey (SS, JD, AM, JW) and Department of Urology, Queen\u2019s University, Kingston General Hospital, Ontario, Canada (JCN)"}]}, {"given": "JOHN D.", "family": "McCONNELL", "sequence": "additional", "affiliation": [{"name": "From The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas (CGR, JDM), Clinical Science Center, University of Wisconsin, (RB) and Jackson Foundation (GHM), Madison, Wisconsin, Harvard Medical School, Boston, Massachusetts (BS), South Florida Medical Research, Aventura, Florida (MCG), Seattle, Washington (JEG), Merck Research Laboratories, Rahway, New Jersey (SS, JD, AM, JW) and Department of Urology, Queen\u2019s University, Kingston General Hospital, Ontario, Canada (JCN)"}]}, {"given": "BRIAN", "family": "SALTZMAN", "sequence": "additional", "affiliation": [{"name": "From The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas (CGR, JDM), Clinical Science Center, University of Wisconsin, (RB) and Jackson Foundation (GHM), Madison, Wisconsin, Harvard Medical School, Boston, Massachusetts (BS), South Florida Medical Research, Aventura, Florida (MCG), Seattle, Washington (JEG), Merck Research Laboratories, Rahway, New Jersey (SS, JD, AM, JW) and Department of Urology, Queen\u2019s University, Kingston General Hospital, Ontario, Canada (JCN)"}]}, {"given": "MARC C.", "family": "GITTELMAN", "sequence": "additional", "affiliation": [{"name": "From The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas (CGR, JDM), Clinical Science Center, University of Wisconsin, (RB) and Jackson Foundation (GHM), Madison, Wisconsin, Harvard Medical School, Boston, Massachusetts (BS), South Florida Medical Research, Aventura, Florida (MCG), Seattle, Washington (JEG), Merck Research Laboratories, Rahway, New Jersey (SS, JD, AM, JW) and Department of Urology, Queen\u2019s University, Kingston General Hospital, Ontario, Canada (JCN)"}]}, {"given": "GHOLEM H.", "family": "MALEK", "sequence": "additional", "affiliation": [{"name": "From The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas (CGR, JDM), Clinical Science Center, University of Wisconsin, (RB) and Jackson Foundation (GHM), Madison, Wisconsin, Harvard Medical School, Boston, Massachusetts (BS), South Florida Medical Research, Aventura, Florida (MCG), Seattle, Washington (JEG), Merck Research Laboratories, Rahway, New Jersey (SS, JD, AM, JW) and Department of Urology, Queen\u2019s University, Kingston General Hospital, Ontario, Canada (JCN)"}]}, {"given": "JAMES E.", "family": "GOTTESMAN", "sequence": "additional", "affiliation": [{"name": "From The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas (CGR, JDM), Clinical Science Center, University of Wisconsin, (RB) and Jackson Foundation (GHM), Madison, Wisconsin, Harvard Medical School, Boston, Massachusetts (BS), South Florida Medical Research, Aventura, Florida (MCG), Seattle, Washington (JEG), Merck Research Laboratories, Rahway, New Jersey (SS, JD, AM, JW) and Department of Urology, Queen\u2019s University, Kingston General Hospital, Ontario, Canada (JCN)"}]}, {"given": "SHILAJA", "family": "SURYAWANSHI", "sequence": "additional", "affiliation": [{"name": "From The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas (CGR, JDM), Clinical Science Center, University of Wisconsin, (RB) and Jackson Foundation (GHM), Madison, Wisconsin, Harvard Medical School, Boston, Massachusetts (BS), South Florida Medical Research, Aventura, Florida (MCG), Seattle, Washington (JEG), Merck Research Laboratories, Rahway, New Jersey (SS, JD, AM, JW) and Department of Urology, Queen\u2019s University, Kingston General Hospital, Ontario, Canada (JCN)"}]}, {"given": "JENNIFER", "family": "DRISKO", "sequence": "additional", "affiliation": [{"name": "From The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas (CGR, JDM), Clinical Science Center, University of Wisconsin, (RB) and Jackson Foundation (GHM), Madison, Wisconsin, Harvard Medical School, Boston, Massachusetts (BS), South Florida Medical Research, Aventura, Florida (MCG), Seattle, Washington (JEG), Merck Research Laboratories, Rahway, New Jersey (SS, JD, AM, JW) and Department of Urology, Queen\u2019s University, Kingston General Hospital, Ontario, Canada (JCN)"}]}, {"given": "ALAN", "family": "MEEHAN", "sequence": "additional", "affiliation": [{"name": "From The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas (CGR, JDM), Clinical Science Center, University of Wisconsin, (RB) and Jackson Foundation (GHM), Madison, Wisconsin, Harvard Medical School, Boston, Massachusetts (BS), South Florida Medical Research, Aventura, Florida (MCG), Seattle, Washington (JEG), Merck Research Laboratories, Rahway, New Jersey (SS, JD, AM, JW) and Department of Urology, Queen\u2019s University, Kingston General Hospital, Ontario, Canada (JCN)"}]}, {"given": "JOANNE", "family": "WALDSTREICHER", "sequence": "additional", "affiliation": [{"name": "From The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas (CGR, JDM), Clinical Science Center, University of Wisconsin, (RB) and Jackson Foundation (GHM), Madison, Wisconsin, Harvard Medical School, Boston, Massachusetts (BS), South Florida Medical Research, Aventura, Florida (MCG), Seattle, Washington (JEG), Merck Research Laboratories, Rahway, New Jersey (SS, JD, AM, JW) and Department of Urology, Queen\u2019s University, Kingston General Hospital, Ontario, Canada (JCN)"}]}, {"name": "FOR THE PROSCAR LONG-TERM EFFICACY AND SAFETY STUDY GROUP", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Journal of Urology"], "language": "en", "link": [{"URL": "http://api.elsevier.com/content/article/PII:S0022534705624421?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://api.elsevier.com/content/article/PII:S0022534705624421?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 7, 2]], "date-time": "2019-07-02T14:14:43Z", "timestamp": 1562076883000}, "score": 62.086067, "issued": {"date-parts": [[2004, 3]]}, "references-count": 12, "journal-issue": {"published-print": {"date-parts": [[2004, 3]]}, "issue": "3"}, "alternative-id": ["10.1097/01.ju.0000112918.74410.94"], "URL": "http://dx.doi.org/10.1097/01.ju.0000112918.74410.94", "ISSN": ["0022-5347", "1527-3792"], "issn-type": [{"value": "0022-5347", "type": "print"}, {"value": "1527-3792", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T19:29:12Z", "timestamp": 1574364552877}, "reference-count": 1, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2007, 1, 1]], "date-time": "2007-01-01T00:00:00Z", "timestamp": 1167609600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Yearbook of Urology"], "published-print": {"date-parts": [[2007, 1]]}, "DOI": "10.1016/s0084-4071(08)70068-x", "type": "journal-article", "created": {"date-parts": [[2008, 4, 17]], "date-time": "2008-04-17T20:57:34Z", "timestamp": 1208465854000}, "page": "88-89", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Development of nomogram to predict acute urinary retention or surgical intervention, with or without dutasteride therapy, in men with benign prostatic hyperplasia"], "prefix": "10.1016", "volume": "2007", "author": [{"given": "C.G.", "family": "Roehrborn", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Yearbook of Urology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S008440710870068X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S008440710870068X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 29]], "date-time": "2018-12-29T23:23:37Z", "timestamp": 1546125817000}, "score": 61.104256, "issued": {"date-parts": [[2007, 1]]}, "references-count": 1, "alternative-id": ["S008440710870068X"], "URL": "http://dx.doi.org/10.1016/s0084-4071(08)70068-x", "ISSN": ["0084-4071"], "issn-type": [{"value": "0084-4071", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T19:29:52Z", "timestamp": 1574364592593}, "reference-count": 2, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2007, 1, 1]], "date-time": "2007-01-01T00:00:00Z", "timestamp": 1167609600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Yearbook of Urology"], "published-print": {"date-parts": [[2007, 1]]}, "DOI": "10.1016/s0084-4071(08)70083-6", "type": "journal-article", "created": {"date-parts": [[2008, 4, 17]], "date-time": "2008-04-17T21:16:36Z", "timestamp": 1208466996000}, "page": "105-107", "source": "Crossref", "is-referenced-by-count": 0, "title": ["The management of acute urinary retention in France: a cross-sectional survey in 2618 men with benign prostatic hyperplasia"], "prefix": "10.1016", "volume": "2007", "author": [{"given": "C.G.", "family": "Roehrborn", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Yearbook of Urology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0084407108700836?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0084407108700836?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 29]], "date-time": "2018-12-29T22:28:31Z", "timestamp": 1546122511000}, "score": 61.104256, "issued": {"date-parts": [[2007, 1]]}, "references-count": 2, "alternative-id": ["S0084407108700836"], "URL": "http://dx.doi.org/10.1016/s0084-4071(08)70083-6", "ISSN": ["0084-4071"], "issn-type": [{"value": "0084-4071", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T13:39:01Z", "timestamp": 1574170741307}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2003, 2, 1]], "date-time": "2003-02-01T00:00:00Z", "timestamp": 1044057600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Urology Supplements"], "published-print": {"date-parts": [[2003, 2]]}, "DOI": "10.1016/s1569-9056(03)80631-0", "type": "journal-article", "created": {"date-parts": [[2003, 8, 8]], "date-time": "2003-08-08T01:06:34Z", "timestamp": 1060304794000}, "page": "160", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Effect of finasteride on serum testosterone in men with benign prostatic hyperplasia and low testosterone levels"], "prefix": "10.1016", "volume": "2", "author": [{"given": "C.", "family": "Roehrborn", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["European Urology Supplements"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1569905603806310?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1569905603806310?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 3, 15]], "date-time": "2019-03-15T04:56:50Z", "timestamp": 1552625810000}, "score": 57.32109, "issued": {"date-parts": [[2003, 2]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2003, 2]]}, "issue": "1"}, "alternative-id": ["S1569905603806310"], "URL": "http://dx.doi.org/10.1016/s1569-9056(03)80631-0", "ISSN": ["1569-9056"], "issn-type": [{"value": "1569-9056", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T19:29:52Z", "timestamp": 1574364592587}, "reference-count": 1, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2007, 1, 1]], "date-time": "2007-01-01T00:00:00Z", "timestamp": 1167609600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Yearbook of Urology"], "published-print": {"date-parts": [[2007, 1]]}, "DOI": "10.1016/s0084-4071(08)70082-4", "type": "journal-article", "created": {"date-parts": [[2008, 4, 17]], "date-time": "2008-04-17T21:16:36Z", "timestamp": 1208466996000}, "page": "104-105", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Sustained beneficial effects of intraprostatic botulinum toxin type A on lower urinary tract symptoms and quality of life in men with benign prostatic hyperplasia"], "prefix": "10.1016", "volume": "2007", "author": [{"given": "C.G.", "family": "Roehrborn", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Yearbook of Urology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0084407108700824?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0084407108700824?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 29]], "date-time": "2018-12-29T22:28:32Z", "timestamp": 1546122512000}, "score": 56.837223, "issued": {"date-parts": [[2007, 1]]}, "references-count": 1, "alternative-id": ["S0084407108700824"], "URL": "http://dx.doi.org/10.1016/s0084-4071(08)70082-4", "ISSN": ["0084-4071"], "issn-type": [{"value": "0084-4071", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T22:44:59Z", "timestamp": 1574549099577}, "publisher-location": "Chichester, UK", "reference-count": 51, "publisher": "John Wiley & Sons, Ltd", "isbn-type": [{"value": "9781118437995", "type": "print"}, {"value": "9781118437889", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1002/9781118437889.ch11", "type": "book-chapter", "created": {"date-parts": [[2014, 9, 27]], "date-time": "2014-09-27T03:03:15Z", "timestamp": 1411786995000}, "page": "129-153", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Combination Medical Therapy for Male Lower Urinary Tract Symptoms"], "prefix": "10.1002", "author": [{"given": "Claus G.", "family": "Roehrborn", "sequence": "first", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2014, 9, 26]]}, "reference": [{"issue": "2", "key": "10.1002/9781118437889.ch11-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "228", "DOI": "10.1016/j.eururo.2013.01.018", "article-title": "Systematic review of combination drug therapy for non-neurogenic male lower urinary tract symptoms", "volume": "64", "author": "Fullhase", "year": "2013", "journal-title": "Eur Urol"}, {"issue": "3", "key": "10.1002/9781118437889.ch11-BIB2|cit2", "doi-asserted-by": "crossref", "first-page": "193", "DOI": "10.1111/j.1442-2042.2007.01956.x", "article-title": "Alpha1-adrenoceptor subtypes and lower urinary tract symptoms", "volume": "15", "author": "Schwinn", "year": "2008", "journal-title": "Int J Urol"}, {"issue": "3", "key": "10.1002/9781118437889.ch11-BIB3|cit3", "doi-asserted-by": "crossref", "first-page": "1029", "DOI": "10.1097/01.ju.0000097026.43866.cc", "article-title": "Alpha1-adrenergic receptors and their inhibitors in lower urinary tract symptoms and benign prostatic hyperplasia", "volume": "171", "author": "Roehrborn", "year": "2004", "journal-title": "J Urol"}, {"issue": "Suppl 2", "key": "10.1002/9781118437889.ch11-BIB4|cit4", "doi-asserted-by": "crossref", "first-page": "27", "DOI": "10.1046/j.1464-410X.2001.00116.x", "article-title": "The role of alpha1-adrenergic receptor subtypes in lower urinary tract symptoms", "volume": "88", "author": "Schwinn", "year": "2001", "journal-title": "BJU Int."}, {"issue": "2", "key": "10.1002/9781118437889.ch11-BIB5|cit5", "doi-asserted-by": "crossref", "first-page": "254", "DOI": "10.1016/S0169-328X(98)00287-3", "article-title": "Alpha1-adrenergic receptors in human spinal cord: specific localized expression of mRNA encoding alpha1-adrenergic receptor subtypes at four distinct levels", "volume": "63", "author": "Smith", "year": "1999", "journal-title": "Brain Res Mol Brain Res"}, {"issue": "5", "key": "10.1002/9781118437889.ch11-BIB6|cit6", "doi-asserted-by": "crossref", "first-page": "999", "DOI": "10.1016/S0090-4295(00)01052-9", "article-title": "Tissue effects of saw palmetto and finasteride: use of biopsy cores for in situ quantification of prostatic androgens", "volume": "57", "author": "Marks", "year": "2001", "journal-title": "Urology"}, {"issue": "3", "key": "10.1002/9781118437889.ch11-BIB7|cit7", "doi-asserted-by": "crossref", "first-page": "574", "DOI": "10.1016/S0090-4295(98)00567-6", "article-title": "Long-term effects of finasteride on prostate tissue composition", "volume": "53", "author": "Marks", "year": "1999", "journal-title": "Urology"}, {"issue": "6", "key": "10.1002/9781118437889.ch11-BIB8|cit8", "doi-asserted-by": "crossref", "first-page": "2171", "DOI": "10.1016/S0022-5347(01)64707-4", "article-title": "Prostate tissue composition and response to finasteride in men with symptomatic benign prostatic hyperplasia", "volume": "157", "author": "Marks", "year": "1997", "journal-title": "J Urol"}, {"issue": "2", "key": "10.1002/9781118437889.ch11-BIB9|cit9", "doi-asserted-by": "crossref", "first-page": "177", "DOI": "10.1159/000112610", "article-title": "Effect of finasteride treatment on suburethral prostatic microvessel density in patients with hematuria related to benign prostate hyperplasia", "volume": "80", "author": "Memis", "year": "2008", "journal-title": "Urol Int"}, {"issue": "1", "key": "10.1002/9781118437889.ch11-BIB10|cit10", "doi-asserted-by": "crossref", "first-page": "20", "DOI": "10.1016/S0022-5347(05)64025-6", "article-title": "The effect of finasteride on the expression of vascular endothelial growth factor and microvessel density: a possible mechanism for decreased prostatic bleeding in treated patients", "volume": "169", "author": "Pareek", "year": "2003", "journal-title": "J Urol"}, {"issue": "Suppl 2", "key": "10.1002/9781118437889.ch11-BIB11|cit11", "first-page": "208", "article-title": "Peak flow and IPSS changes in patients treated with a combination of finasteride and terazosin after withdrawing terazosin", "volume": "80", "author": "Pushkar", "year": "1997", "journal-title": "Br J Urol"}, {"key": "10.1002/9781118437889.ch11-BIB12|cit12", "first-page": "32", "article-title": "A trial of the use of finasteride and terazosin in patients with benign prostatic hyperplasia", "volume": "4", "author": "Pushkar", "year": "1995", "journal-title": "Urol Nefrol."}, {"issue": "3", "key": "10.1002/9781118437889.ch11-BIB13|cit13", "first-page": "578", "article-title": "Combination medical therapy for symptomatic benign prostatic hyperplasia", "volume": "5", "author": "Savage", "year": "1998", "journal-title": "Can J Urol"}, {"issue": "3", "key": "10.1002/9781118437889.ch11-BIB14|cit14", "doi-asserted-by": "crossref", "first-page": "169", "DOI": "10.1159/000019706", "article-title": "Sustained-release alfuzosin, finasteride and the combination of both in the treatment of benign prostatic hyperplasia. European ALFIN Study Group", "volume": "34", "author": "Debruyne", "year": "1998", "journal-title": "Eur Urol."}, {"issue": "1", "key": "10.1002/9781118437889.ch11-BIB15|cit15", "doi-asserted-by": "crossref", "first-page": "145", "DOI": "10.1097/01.ju.0000069827.09120.79", "article-title": "Changes in nocturia from medical treatment of benign prostatic hyperplasia: secondary analysis of the Department of Veterans Affairs Cooperative Study Trial", "volume": "170", "author": "Johnson", "year": "2003", "journal-title": "J Urol"}, {"issue": "5", "key": "10.1002/9781118437889.ch11-BIB16|cit16", "doi-asserted-by": "crossref", "first-page": "1559", "DOI": "10.1016/S0022-5347(05)67028-0", "article-title": "Filling and voiding symptoms in the American Urological Association Symptom Index: the value of their distinction in a veterans affairs randomized trial of medical therapy in men with a clinical diagnosis of benign prostatic hyperplasia", "volume": "164", "author": "Barry", "year": "2000", "journal-title": "J Urol"}, {"issue": "4", "key": "10.1002/9781118437889.ch11-BIB17|cit17", "doi-asserted-by": "crossref", "first-page": "1134", "DOI": "10.1016/S0022-5347(05)67709-9", "article-title": "The mechanism of adverse events associated with terazosin: an analysis of the Veterans Affairs cooperative study", "volume": "163", "author": "Lepor", "year": "2000", "journal-title": "J Urol"}, {"issue": "4", "key": "10.1002/9781118437889.ch11-BIB18|cit18", "doi-asserted-by": "crossref", "first-page": "234", "DOI": "10.1002/(SICI)1097-0045(19990601)39:4<234::AID-PROS3>3.0.CO;2-4", "article-title": "Effect of finasteride and/or terazosin on serum PSA: results of VA Cooperative Study #359", "volume": "39", "author": "Brawer", "year": "1999", "journal-title": "Prostate"}, {"issue": "4", "key": "10.1002/9781118437889.ch11-BIB19|cit19", "doi-asserted-by": "crossref", "first-page": "1358", "DOI": "10.1016/S0022-5347(01)62536-9", "article-title": "The impact of medical therapy on bother due to symptoms, quality of life and global outcome, and factors predicting response. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group", "volume": "160", "author": "Lepor", "year": "1998", "journal-title": "J Urol."}, {"issue": "8", "key": "10.1002/9781118437889.ch11-BIB20|cit20", "doi-asserted-by": "crossref", "first-page": "533", "DOI": "10.1056/NEJM199608223350801", "article-title": "The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group", "volume": "335", "author": "Lepor", "year": "1996", "journal-title": "N Engl J Med."}, {"issue": "1", "key": "10.1002/9781118437889.ch11-BIB21|cit21", "doi-asserted-by": "crossref", "first-page": "119", "DOI": "10.1016/S0090-4295(02)02114-3", "article-title": "Efficacy and tolerability of doxazosin and finasteride, alone or in combination, in treatment of symptomatic benign prostatic hyperplasia: the Prospective European Doxazosin and Combination Therapy (PREDICT) trial", "volume": "61", "author": "Kirby", "year": "2003", "journal-title": "Urology"}, {"issue": "25", "key": "10.1002/9781118437889.ch11-BIB22|cit22", "doi-asserted-by": "crossref", "first-page": "2387", "DOI": "10.1056/NEJMoa030656", "article-title": "The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia", "volume": "349", "author": "McConnell", "year": "2003", "journal-title": "N Engl J Med"}, {"issue": "1", "key": "10.1002/9781118437889.ch11-BIB23|cit23", "doi-asserted-by": "crossref", "first-page": "123", "DOI": "10.1016/j.eururo.2009.09.035", "article-title": "The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study", "volume": "57", "author": "Roehrborn", "year": "2010", "journal-title": "Eur Urol"}, {"issue": "2", "key": "10.1002/9781118437889.ch11-BIB24|cit24", "doi-asserted-by": "crossref", "first-page": "616", "DOI": "10.1016/j.juro.2007.09.084", "article-title": "The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study", "volume": "179", "author": "Roehrborn", "year": "2008", "journal-title": "J Urol"}, {"issue": "2", "key": "10.1002/9781118437889.ch11-BIB25|cit25", "doi-asserted-by": "crossref", "first-page": "224", "DOI": "10.1016/S0197-2456(02)00263-5", "article-title": "Study design of the Medical Therapy of Prostatic Symptoms (MTOPS) trial", "volume": "24", "author": "Bautista", "year": "2003", "journal-title": "Control Clin Trials"}, {"issue": "4", "key": "10.1002/9781118437889.ch11-BIB26|cit26", "doi-asserted-by": "crossref", "first-page": "369", "DOI": "10.1038/pcan.2009.37", "article-title": "The effects of dutasteride, tamsulosin, and the combination on storage and voiding in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the Combination of Avodart and Tamsulosin study", "volume": "12", "author": "Becher", "year": "2009", "journal-title": "Prostate Cancer Prostatic Dis"}, {"issue": "7", "key": "10.1002/9781118437889.ch11-BIB27|cit27", "doi-asserted-by": "crossref", "first-page": "919", "DOI": "10.1111/j.1464-410X.2009.08196.x", "article-title": "Effect of dutasteride, tamsulosin and the combination on patient-reported quality of life and treatment satisfaction in men with moderate-to-severe benign prostatic hyperplasia: 2-year data from the CombAT trial", "volume": "103", "author": "Barkin", "year": "2009", "journal-title": "BJU Int"}, {"issue": "2", "key": "10.1002/9781118437889.ch11-BIB28|cit28", "doi-asserted-by": "crossref", "first-page": "461", "DOI": "10.1016/j.eururo.2008.10.037", "article-title": "The influence of baseline parameters on changes in international prostate symptom score with dutasteride, tamsulosin, and combination therapy among men with symptomatic benign prostatic hyperplasia and an enlarged prostate: 2-year data from the CombAT study", "volume": "55", "author": "Roehrborn", "year": "2009", "journal-title": "Eur Urol"}, {"issue": "2", "key": "10.1002/9781118437889.ch11-BIB29|cit29", "doi-asserted-by": "crossref", "first-page": "152", "DOI": "10.1038/pcan.2008.49", "article-title": "Efficacy and safety of dutasteride, tamsulosin and their combination in a subpopulation of the CombAT study: 2-year results in Asian men with moderate-to-severe BPH", "volume": "12", "author": "Chung", "year": "2009", "journal-title": "Prostate Cancer Prostatic Dis"}, {"issue": "4", "key": "10.1002/9781118437889.ch11-BIB30|cit30", "doi-asserted-by": "crossref", "first-page": "1422", "DOI": "10.1016/S0022-5347(05)00708-1", "article-title": "Baseline factors as predictors of clinical progression of benign prostatic hyperplasia in men treated with placebo", "volume": "175", "author": "Crawford", "year": "2006", "journal-title": "J Urol"}, {"issue": "3", "key": "10.1002/9781118437889.ch11-BIB31|cit31", "doi-asserted-by": "crossref", "first-page": "562", "DOI": "10.1016/j.urology.2008.05.034", "article-title": "Association of sexual dysfunction with lower urinary tract symptoms of BPH and BPH medical therapies: results from the BPH Registry", "volume": "73", "author": "Rosen", "year": "2009", "journal-title": "Urology"}, {"issue": "4", "key": "10.1002/9781118437889.ch11-BIB32|cit32", "first-page": "525", "article-title": "A comparative study of the efficacy and safety of tamsulosin hydrochloride (Harnal capsules) alone and in combination with propiverine hydrochloride (BUP-4 tablets) in patients with prostatic hypertrophy associated with pollakiuria and/or urinary incontinence", "volume": "12", "author": "Saito", "year": "1999", "journal-title": "Jpn J Urol Surg"}, {"issue": "4 Pt 1", "key": "10.1002/9781118437889.ch11-BIB33|cit33", "doi-asserted-by": "crossref", "first-page": "1334", "DOI": "10.1097/01.ju.0000173630.94559.fd", "article-title": "Combination treatment with propiverine hydrochloride plus doxazosin controlled release gastrointestinal therapeutic system formulation for overactive bladder and coexisting benign prostatic obstruction: a prospective, randomized, controlled multicenter study", "volume": "174", "author": "Lee", "year": "2005", "journal-title": "J Urol"}, {"issue": "19", "key": "10.1002/9781118437889.ch11-BIB34|cit34", "doi-asserted-by": "crossref", "first-page": "2319", "DOI": "10.1001/jama.296.19.2319", "article-title": "Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial", "volume": "296", "author": "Kaplan", "year": "2006", "journal-title": "JAMA"}, {"issue": "3", "key": "10.1002/9781118437889.ch11-BIB35|cit35", "doi-asserted-by": "crossref", "first-page": "1034", "DOI": "10.1016/j.juro.2008.05.050", "article-title": "Effect of tolterodine extended release with or without tamsulosin on measures of urgency and patient reported outcomes in men with lower urinary tract symptoms", "volume": "180", "author": "Rovner", "year": "2008", "journal-title": "J Urol"}, {"issue": "5", "key": "10.1002/9781118437889.ch11-BIB36|cit36", "doi-asserted-by": "crossref", "first-page": "1061", "DOI": "10.1016/j.urology.2008.06.067", "article-title": "Effects of serum PSA on efficacy of tolterodine extended release with or without tamsulosin in men with LUTS, including OAB", "volume": "72", "author": "Roehrborn", "year": "2008", "journal-title": "Urology"}, {"issue": "9", "key": "10.1002/9781118437889.ch11-BIB37|cit37", "doi-asserted-by": "crossref", "first-page": "1002", "DOI": "10.4065/83.9.1002", "article-title": "Efficacy and safety of extended-release oxybutynin in combination with tamsulosin for treatment of lower urinary tract symptoms in men: randomized, double-blind, placebo-controlled study", "volume": "83", "author": "MacDiarmid", "year": "2008", "journal-title": "Mayo Clin Proc"}, {"issue": "9", "key": "10.1002/9781118437889.ch11-BIB38|cit38", "doi-asserted-by": "crossref", "first-page": "1133", "DOI": "10.1111/j.1464-410X.2008.07761.x", "article-title": "Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score", "volume": "102", "author": "Kaplan", "year": "2008", "journal-title": "BJU Int"}, {"issue": "2", "key": "10.1002/9781118437889.ch11-BIB39|cit39", "doi-asserted-by": "crossref", "first-page": "472", "DOI": "10.1016/j.eururo.2008.06.032", "article-title": "Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effects of prostate size", "volume": "55", "author": "Roehrborn", "year": "2009", "journal-title": "Eur Urol"}, {"issue": "6", "key": "10.1002/9781118437889.ch11-BIB40|cit40", "doi-asserted-by": "crossref", "first-page": "2825", "DOI": "10.1016/j.juro.2009.08.023", "article-title": "Safety and tolerability of solifenacin add-on therapy to alpha-blocker treated men with residual urgency and frequency", "volume": "182", "author": "Kaplan", "year": "2009", "journal-title": "J Urol"}, {"issue": "3", "key": "10.1002/9781118437889.ch11-BIB41|cit41", "doi-asserted-by": "crossref", "first-page": "534", "DOI": "10.1016/j.eururo.2008.11.026", "article-title": "Tolterodine treatment improves storage symptoms suggestive of overactive bladder in men treated with alpha-blockers", "volume": "56", "author": "Chapple", "year": "2009", "journal-title": "Eur Urol"}, {"issue": "1", "key": "10.1002/9781118437889.ch11-BIB42|cit42", "doi-asserted-by": "crossref", "first-page": "126", "DOI": "10.1016/j.urology.2011.02.055", "article-title": "Solifenacin as add-on therapy for overactive bladder symptoms in men treated for lower urinary tract symptoms - ASSIST, randomized controlled study", "volume": "78", "author": "Yamaguchi", "year": "2011", "journal-title": "Urology"}, {"issue": "9", "key": "10.1002/9781118437889.ch11-BIB43|cit43", "doi-asserted-by": "crossref", "first-page": "1332", "DOI": "10.1111/j.1464-410X.2010.09359.x", "article-title": "Efficacy and safety of tolterodine extended-release in men with overactive bladder symptoms treated with an alpha-blocker: effect of baseline prostate-specific antigen concentration", "volume": "106", "author": "Chapple", "journal-title": "BJU Int"}, {"issue": "2", "key": "10.1002/9781118437889.ch11-BIB44|cit44", "doi-asserted-by": "crossref", "first-page": "217", "DOI": "10.1007/s00345-011-0654-7", "article-title": "Efficacy of propiverine ER with or without alpha-blockers related to maximum urinary flow rate in adult men with OAB: results of a 12-week, multicenter, non-interventional study", "volume": "29", "author": "Oelke", "journal-title": "World J Urol"}, {"key": "10.1002/9781118437889.ch11-BIB45|cit45", "first-page": "29", "article-title": "Randomized controlled trial to treat benign prostatic hyperplasia with overactive bladder using an alpha-blocker combined with anticholinergics", "volume": "3", "author": "Nishizawa", "year": "2011", "journal-title": "LUTS."}, {"issue": "6", "key": "10.1002/9781118437889.ch11-BIB46|cit46", "doi-asserted-by": "crossref", "first-page": "1717", "DOI": "10.1016/j.eururo.2007.01.033", "article-title": "Combination of alfuzosin and sildenafil is superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction", "volume": "51", "author": "Kaplan", "year": "2007", "journal-title": "Eur Urol"}, {"issue": "9", "key": "10.1002/9781118437889.ch11-BIB47|cit47", "doi-asserted-by": "crossref", "first-page": "2170", "DOI": "10.1111/j.1743-6109.2008.00940.x", "article-title": "Comparative efficacy assessment of tamsulosin vs tamsulosin plus tadalafil in the treatment of LUTS/BPH. Pilot study", "volume": "5", "author": "Bechara", "year": "2008", "journal-title": "J Sex Med."}, {"issue": "1", "key": "10.1002/9781118437889.ch11-BIB48|cit48", "doi-asserted-by": "crossref", "first-page": "17", "DOI": "10.1007/s00345-009-0484-z", "article-title": "Sildenafil citrate and tamsulosin combination is not superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction", "volume": "28", "author": "Tuncel", "year": "2010", "journal-title": "World J Urol"}, {"issue": "6", "key": "10.1002/9781118437889.ch11-BIB49|cit49", "doi-asserted-by": "crossref", "first-page": "1624", "DOI": "10.1111/j.1743-6109.2012.02718.x", "article-title": "A randomized, placebo-controlled study to assess safety and efficacy of vardenafil 10 mg and tamsulosin 0.4 mg vs tamsulosin 0.4 mg alone in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia", "volume": "9", "author": "Gacci", "year": "2012", "journal-title": "J Sex Med"}, {"issue": "2", "key": "10.1002/9781118437889.ch11-BIB50|cit50", "doi-asserted-by": "crossref", "first-page": "544", "DOI": "10.1111/j.1743-6109.2008.01109.x", "article-title": "Efficacy and safety of combined oral therapy with tadalafil and alfuzosin: an integrated approach to the management of patients with lower urinary tract symptoms and erectile dysfunction. Preliminary report", "volume": "6", "author": "Liguori", "year": "2009", "journal-title": "J Sex Med."}, {"issue": "5", "key": "10.1002/9781118437889.ch11-BIB51|cit51", "doi-asserted-by": "crossref", "first-page": "994", "DOI": "10.1016/j.eururo.2012.02.033", "article-title": "A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with alpha-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia", "volume": "61", "author": "Gacci", "year": "2012", "journal-title": "Eur Urol"}], "container-title": ["Male Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia"], "link": [{"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/9781118437889.ch11", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 8, 5]], "date-time": "2018-08-05T22:35:29Z", "timestamp": 1533508529000}, "score": 55.463795, "issued": {"date-parts": [[2014, 9, 26]]}, "ISBN": ["9781118437889", "9781118437995"], "references-count": 51, "URL": "http://dx.doi.org/10.1002/9781118437889.ch11", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T11:43:27Z", "timestamp": 1575200607210}, "reference-count": 35, "publisher": "CRC Press", "isbn-type": [{"value": "9781841846019", "type": "print"}, {"value": "9780203088050", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2005, 6, 16]]}, "DOI": "10.1201/b14479-3", "type": "book-chapter", "created": {"date-parts": [[2013, 3, 20]], "date-time": "2013-03-20T15:29:18Z", "timestamp": 1363793358000}, "page": "11-39", "source": "Crossref", "is-referenced-by-count": 0, "title": ["The placebo effect in the treatment of benign prostatic hyperplasia"], "prefix": "10.1201", "author": [{"given": "C", "family": "Roehrborn", "sequence": "first", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2013, 3, 20]]}, "reference": [{"key": "p_4", "DOI": "10.1136/bmj.1.5337.1043", "doi-asserted-by": "publisher"}, {"key": "p_5", "author": "Macedo A", "volume-title": "Sypherd D, Machi G et al. Randomized tual and historical considerations. Eur J Clin double-blind study comparing the effectiveness of Pharmacol 2003"}, {"key": "p_7", "volume": "147", "first-page": "639", "year": "1992", "journal-title": "J Urol", "DOI": "10.1016/S0022-5347(17)37331-7", "doi-asserted-by": "crossref"}, {"key": "p_12", "unstructured": "1961; 344: 203-205 cal use of placebo controls. N Engl J Med 1994; 331:", "DOI": "10.1056/NEJM199407213310315", "doi-asserted-by": "crossref"}, {"key": "p_14", "author": "Shapiro A K", "volume-title": "McConnell J D, Yoshida O et al. medical and psychological therapies. In: Garfield S Recommendations of the International Scientific L"}, {"key": "p_15", "author": "Brody H.", "year": "1977", "volume-title": "Denis L"}, {"key": "p_18", "unstructured": "de la Fuente-Fernandez R, Schulzer M, Stoessl A J. The placebo effect in neurological disorders. (eds). 5th International Consultation on Benign"}, {"key": "p_19", "DOI": "10.1016/S1474-4422(02)00038-8", "doi-asserted-by": "publisher"}, {"key": "p_20", "author": "Brody H.", "volume-title": "White L, Tursky B, 22"}, {"key": "p_24", "DOI": "10.1001/jama.1994.03510440069036", "doi-asserted-by": "publisher"}, {"key": "p_25", "DOI": "10.1001/jama.1955.02960340022006", "doi-asserted-by": "publisher"}, {"key": "p_28", "author": "Rosenzweig P", "year": "1993", "volume-title": "The placebo County Study of Urinary Symptoms and Health effect in healthy volunteers: influence of experi- Status"}, {"key": "p_29", "DOI": "10.1016/S0090-4295(03)00154-7", "doi-asserted-by": "publisher"}, {"key": "p_30", "DOI": "10.1056/NEJM195905282602204", "doi-asserted-by": "publisher"}, {"key": "p_33", "unstructured": "1960; 5: 483-486 munity based cohort of older men. J Urol 2002; 168:"}, {"key": "p_37", "DOI": "10.1016/S0090-4295(97)00609-2", "doi-asserted-by": "publisher"}, {"key": "p_39", "author": "Guess H A", "volume": "150", "year": "1993", "journal-title": "J Urol", "DOI": "10.1016/S0022-5347(17)35871-8", "doi-asserted-by": "crossref"}, {"key": "p_40", "DOI": "10.1016/S0022-5347(05)68049-4", "doi-asserted-by": "publisher"}, {"key": "p_41", "author": "Rhodes T", "volume": "148", "first-page": "1546", "year": "1992", "journal-title": "J Urol", "DOI": "10.1016/S0022-5347(17)36965-3", "doi-asserted-by": "crossref"}, {"key": "p_42", "DOI": "10.1016/S0022-5347(01)61621-5", "doi-asserted-by": "publisher"}, {"key": "p_43", "author": "Diokno A C", "volume": "148", "first-page": "1817", "year": "1992", "journal-title": "J Urol", "DOI": "10.1016/S0022-5347(17)37038-6", "doi-asserted-by": "crossref"}, {"key": "p_45", "author": "Craigen A A", "volume": "148", "first-page": "1969", "year": "1992", "journal-title": "J R Coll Urological Association. J Urol"}, {"key": "p_46", "DOI": "10.1016/0090-4295(76)90560-4", "doi-asserted-by": "publisher"}, {"key": "p_47", "author": "Kok E T", "volume-title": "Stolk E A et al"}, {"key": "p_49", "author": "Kadow C", "volume": "42", "first-page": "491", "year": "2002", "journal-title": "Br J Urol"}, {"key": "p_51", "DOI": "10.1016/S0302-2838(02)00021-0", "doi-asserted-by": "publisher"}, {"key": "p_53", "author": "AUA BPH Guideline Update Panel", "volume": "60", "year": "1987", "journal-title": "Br J Urol"}, {"key": "p_54", "DOI": "10.1111/j.1464-410X.1990.tb14865.x", "doi-asserted-by": "publisher"}, {"key": "p_56", "DOI": "10.1007/BF00272701", "doi-asserted-by": "publisher"}, {"key": "p_57", "author": "Madsen P O", "volume": "132", "first-page": "1235", "year": "1984", "journal-title": "J Urol", "DOI": "10.1016/S0022-5347(17)50112-3", "doi-asserted-by": "crossref"}, {"key": "p_58", "author": "Gillenwater J Y", "volume": "152", "first-page": "453", "year": "1994", "journal-title": "Urol", "DOI": "10.1016/S0022-5347(17)32761-1", "doi-asserted-by": "crossref"}, {"key": "p_59", "author": "Roehrborn C G", "volume-title": "Stoner E, Bruskewitz R C et al. The The Hytrin Community Assessment Trial study: a effect of finasteride in men with benign prostatic one-year study of terazosin versus placebo in the hyperplasia"}, {"key": "p_61", "DOI": "10.1016/S0090-4295(99)00232-0", "doi-asserted-by": "publisher"}, {"key": "p_63", "DOI": "10.1056/NEJM199802263380901", "doi-asserted-by": "publisher"}, {"key": "p_67", "DOI": "10.1016/0140-6736(93)92482-9", "doi-asserted-by": "publisher"}], "container-title": ["Therapeutic Treatment for Benign Prostatic Hyperplasia"], "link": [{"URL": "http://www.crcnetbase.com/doi/pdf/10.1201/b14479-3", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 7, 11]], "date-time": "2019-07-11T05:00:31Z", "timestamp": 1562821231000}, "score": 54.124813, "issued": {"date-parts": [[2005, 6, 16]]}, "ISBN": ["9781841846019", "9780203088050"], "references-count": 35, "alternative-id": ["10.1201/b14479-3", "10.1201/b14479"], "URL": "http://dx.doi.org/10.1201/b14479-3", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T05:58:31Z", "timestamp": 1574834311782}, "reference-count": 22, "publisher": "Springer Science and Business Media LLC", "issue": "1", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2016, 8, 31]], "date-time": "2016-08-31T00:00:00Z", "timestamp": 1472601600000}, "delay-in-days": 0, "content-version": "unspecified"}], "funder": [{"name": "This work was supported by a grant from GlaxoSmithKline", "award": []}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["BMC Urol"], "published-print": {"date-parts": [[2016, 12]]}, "DOI": "10.1186/s12894-016-0170-6", "type": "journal-article", "created": {"date-parts": [[2016, 9, 2]], "date-time": "2016-09-02T15:55:27Z", "timestamp": 1472831727000}, "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 5, "title": ["Rates of prostate surgery and acute urinary retention for benign prostatic hyperplasia in men treated with dutasteride or finasteride"], "prefix": "10.1186", "volume": "16", "author": [{"given": "Josephina G.", "family": "Kuiper", "sequence": "first", "affiliation": []}, {"given": "Irene D.", "family": "Bezemer", "sequence": "additional", "affiliation": []}, {"given": "Maurice T.", "family": "Driessen", "sequence": "additional", "affiliation": []}, {"given": "Averyan", "family": "Vasylyev", "sequence": "additional", "affiliation": []}, {"given": "Claus G.", "family": "Roehrborn", "sequence": "additional", "affiliation": []}, {"given": "Fernie J. A.", "family": "Penning-van Beest", "sequence": "additional", "affiliation": []}, {"given": "Ron M. C.", "family": "Herings", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2016, 8, 31]]}, "reference": [{"key": "170_CR1", "doi-asserted-by": "publisher", "first-page": "511", "DOI": "10.2147/CIA.S3635", "volume": "3", "author": "CG Roehrborn", "year": "2008", "unstructured": "Roehrborn CG, Rosen RC. Medical therapy options for aging men with benign prostatic hyperplasia: focus on alfuzosin 10\u00a0mg once daily. Clin Interv Aging. 2008;3:511\u201324.", "journal-title": "Clin Interv Aging"}, {"key": "170_CR2", "doi-asserted-by": "crossref", "first-page": "474", "DOI": "10.1016/S0022-5347(17)49698-4", "volume": "132", "author": "SJ Berry", "year": "1984", "unstructured": "Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol. 1984;132:474\u20139.", "journal-title": "J Urol"}, {"issue": "Suppl 2", "key": "170_CR3", "doi-asserted-by": "publisher", "first-page": "3", "DOI": "10.1111/j.1464-410X.2006.06097.x", "volume": "97", "author": "JM Fitzpatrick", "year": "2006", "unstructured": "Fitzpatrick JM. The natural history of benign prostatic hyperplasia. BJU Int. 2006;97 Suppl 2:3\u20136. discussion 21-22.", "journal-title": "BJU Int"}, {"key": "170_CR4", "unstructured": "Roehrborn CG, Oyarzabal Perez I, Roos EP, Calomfirescu N, Brotherton B, Wang F, Palacios JM, Vasylyev A, Manyak MJ. Efficacy and safety of a fixed-dose combination of dutasteride and tamsulosin treatment (Duodart((R))) compared with watchful waiting with initiation of tamsulosin therapy if symptoms do not improve, both provided with lifestyle advice, in the management of treatment-naive men with moderately symptomatic benign prostatic hyperplasia: 2-year CONDUCT study results. BJU Int. 2015;116:450\u201359.", "DOI": "10.1111/bju.13033", "doi-asserted-by": "crossref"}, {"key": "170_CR5", "doi-asserted-by": "publisher", "first-page": "123", "DOI": "10.1016/j.eururo.2009.09.035", "volume": "57", "author": "CG Roehrborn", "year": "2010", "unstructured": "Roehrborn CG, Siami P, Barkin J, Damiao R, Major-Walker K, Nandy I, Morrill BB, Gagnier RP, Montorsi F, Comb ATSG. The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study. Eur Urol. 2010;57:123\u201331.", "journal-title": "Eur Urol"}, {"key": "170_CR6", "doi-asserted-by": "publisher", "first-page": "434", "DOI": "10.1016/S0090-4295(02)01905-2", "volume": "60", "author": "CG Roehrborn", "year": "2002", "unstructured": "Roehrborn CG, Boyle P, Nickel JC, Hoefner K, Andriole G. Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia. Urology. 2002;60:434\u201341.", "journal-title": "Urology"}, {"key": "170_CR7", "doi-asserted-by": "publisher", "first-page": "2179", "DOI": "10.1210/jc.2003-030330", "volume": "89", "author": "RV Clark", "year": "2004", "unstructured": "Clark RV, Hermann DJ, Cunningham GR, Wilson TH, Morrill BB, Hobbs S. Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor. J Clin Endocrinol Metab. 2004;89:2179\u201384.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "170_CR8", "doi-asserted-by": "publisher", "first-page": "388", "DOI": "10.1111/j.1464-410X.2011.10195.x", "volume": "108", "author": "JC Nickel", "year": "2011", "unstructured": "Nickel JC, Gilling P, Tammela TL, Morrill B, Wilson TH, Rittmaster RS. Comparison of dutasteride and finasteride for treating benign prostatic hyperplasia: the Enlarged Prostate International Comparator Study (EPICS). BJU Int. 2011;108:388\u201394.", "journal-title": "BJU Int"}, {"key": "170_CR9", "doi-asserted-by": "publisher", "first-page": "557", "DOI": "10.1056/NEJM199802263380901", "volume": "338", "author": "JD McConnell", "year": "1998", "unstructured": "McConnell JD, Bruskewitz R, Walsh P, Andriole G, Lieber M, Holtgrewe HL, Albertsen P, Roehrborn CG, Nickel JC, Wang DZ, Finasteride Long-Term Efficacy and Safety Study Group, et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. N Engl J Med. 1998;338:557\u201363.", "journal-title": "N Engl J Med"}, {"key": "170_CR10", "doi-asserted-by": "publisher", "first-page": "488", "DOI": "10.1016/j.eururo.2004.05.008", "volume": "46", "author": "F Debruyne", "year": "2004", "unstructured": "Debruyne F, Barkin J, van Erps P, Reis M, Tammela TL, Roehrborn C. Efficacy and safety of long-term treatment with the dual 5 alpha-reductase inhibitor dutasteride in men with symptomatic benign prostatic hyperplasia. Eur Urol. 2004;46:488\u201394. discussion 495.", "journal-title": "Eur Urol"}, {"key": "170_CR11", "first-page": "S154", "volume": "14", "author": "TC Fenter", "year": "2008", "unstructured": "Fenter TC, Davis EA, Shah MB, Lin PJ. Dutasteride vs finasteride: assessment of differences in acute urinary retention rates and surgical risk outcomes in an elderly population aged\u2009>\u2009or =65\u00a0years. Am J Manag Care. 2008;14:S154\u2013159.", "journal-title": "Am J Manag Care"}, {"issue": "Suppl 1", "key": "170_CR12", "first-page": "S10", "volume": "13", "author": "MM Issa", "year": "2007", "unstructured": "Issa MM, Runken MC, Grogg AL, Shah MB. A large retrospective analysis of acute urinary retention and prostate-related surgery in BPH patients treated with 5-alpha reductase inhibitors: dutasteride versus finasteride. Am J Manag Care. 2007;13 Suppl 1:S10\u201316.", "journal-title": "Am J Manag Care"}, {"key": "170_CR13", "doi-asserted-by": "publisher", "first-page": "665", "DOI": "10.1007/s00345-012-1000-4", "volume": "31", "author": "L Cindolo", "year": "2013", "unstructured": "Cindolo L, Fanizza C, Romero M, Pirozzi L, Autorino R, Berardinelli F, Schips L. The effects of dutasteride and finasteride on BPH-related hospitalization, surgery and prostate cancer diagnosis: a record-linkage analysis. World J Urol. 2013;31:665\u201371.", "journal-title": "World J Urol"}, {"key": "170_CR14", "unstructured": "Foundation DHD: www.dutchhospitaldata.nl . Accessed 14 June 2016."}, {"key": "170_CR15", "unstructured": "WHO International Classification of Diseases. [ www.who.int ]. Accessed 14 June 2016."}, {"key": "170_CR16", "unstructured": "Dutch Classification of Procedures. [ www.dhd.nl ]. Accessed 14 June 2016."}, {"key": "170_CR17", "unstructured": "Care ICoP: https://www.nhg.org/themas/artikelen/icpc . Accessed 25 Aug 2016."}, {"key": "170_CR18", "unstructured": "WHO Anatomical Therapeutic Chemical Classification System. [ www.whocc.no ]. Accessed 14 June 2016."}, {"key": "170_CR19", "doi-asserted-by": "publisher", "first-page": "417", "DOI": "10.1046/j.1524-4733.2000.36006.x", "volume": "3", "author": "V Catalan", "year": "2000", "unstructured": "Catalan V, Lelorier J. Predictors of long-term persistence on statins in a subsidized clinical population. Value in Health. 2000;3:417\u201326.", "journal-title": "Value in Health"}, {"key": "170_CR20", "doi-asserted-by": "publisher", "first-page": "149", "DOI": "10.1038/sj.pcan.4500931", "volume": "10", "author": "R Wurzel", "year": "2007", "unstructured": "Wurzel R, Ray P, Major-Walker K, Shannon J, Rittmaster R. The effect of dutasteride on intraprostatic dihydrotestosterone concentrations in men with benign prostatic hyperplasia. Prostate Cancer Prostatic Dis. 2007;10:149\u201354.", "journal-title": "Prostate Cancer Prostatic Dis"}, {"key": "170_CR21", "author": "NV Urologie", "year": "2006", "unstructured": "Urologie NV. Richtlijn Diagostiek en behandeling van LUTS/BPH. 2006.", "volume-title": "Richtlijn Diagostiek en behandeling van LUTS/BPH"}, {"key": "170_CR22", "unstructured": "Dijstelbloem DALA, Schouten MA, Lagro-Janssen ALM. Benigne prostaathyperplasie in vierhuisartsenpraktijken. V\u00f3\u00f3rkomen, beleid en beloop. Huisarts Wet. 2003;46(3):133\u201337.", "DOI": "10.1007/BF03083541", "doi-asserted-by": "crossref"}], "container-title": ["BMC Urology"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1186/s12894-016-0170-6.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1186/s12894-016-0170-6/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1186/s12894-016-0170-6", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}, {"URL": "http://link.springer.com/content/pdf/10.1186/s12894-016-0170-6.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 9, 13]], "date-time": "2019-09-13T04:50:08Z", "timestamp": 1568350208000}, "score": 53.520416, "issued": {"date-parts": [[2016, 8, 31]]}, "references-count": 22, "journal-issue": {"published-print": {"date-parts": [[2016, 12]]}, "issue": "1"}, "alternative-id": ["170"], "URL": "http://dx.doi.org/10.1186/s12894-016-0170-6", "relation": {"cites": []}, "ISSN": ["1471-2490"], "issn-type": [{"value": "1471-2490", "type": "electronic"}], "article-number": "53"}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T12:49:41Z", "timestamp": 1574167781469}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2002, 1, 1]], "date-time": "2002-01-01T00:00:00Z", "timestamp": 1009843200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Urology Supplements"], "published-print": {"date-parts": [[2002, 1]]}, "DOI": "10.1016/s1569-9056(02)80413-4", "type": "journal-article", "created": {"date-parts": [[2003, 7, 9]], "date-time": "2003-07-09T16:14:27Z", "timestamp": 1057767267000}, "page": "107", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Rapid reduction in risk of AUR and/or surgery with finasteride in men with benign prostatic hyerplasia"], "prefix": "10.1016", "volume": "1", "author": [{"given": "Claus", "family": "Roehrborn", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["European Urology Supplements"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1569905602804134?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1569905602804134?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 3, 18]], "date-time": "2019-03-18T03:22:57Z", "timestamp": 1552879377000}, "score": 49.989655, "issued": {"date-parts": [[2002, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2002, 1]]}, "issue": "1"}, "alternative-id": ["S1569905602804134"], "URL": "http://dx.doi.org/10.1016/s1569-9056(02)80413-4", "ISSN": ["1569-9056"], "issn-type": [{"value": "1569-9056", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T19:29:52Z", "timestamp": 1574364592453}, "reference-count": 1, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2006, 1, 1]], "date-time": "2006-01-01T00:00:00Z", "timestamp": 1136073600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Yearbook of Urology"], "published-print": {"date-parts": [[2006, 1]]}, "DOI": "10.1016/s0084-4071(08)70281-1", "type": "journal-article", "created": {"date-parts": [[2008, 4, 17]], "date-time": "2008-04-17T21:16:36Z", "timestamp": 1208466996000}, "page": "96-98", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Autonomic Nervous System Overactivity in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia"], "prefix": "10.1016", "volume": "2006", "author": [{"given": "C.G.", "family": "Roehrborn", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Yearbook of Urology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0084407108702811?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0084407108702811?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 29]], "date-time": "2018-12-29T22:28:42Z", "timestamp": 1546122522000}, "score": 49.675377, "issued": {"date-parts": [[2006, 1]]}, "references-count": 1, "alternative-id": ["S0084407108702811"], "URL": "http://dx.doi.org/10.1016/s0084-4071(08)70281-1", "ISSN": ["0084-4071"], "issn-type": [{"value": "0084-4071", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T22:48:40Z", "timestamp": 1574117320348}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2004, 2, 1]], "date-time": "2004-02-01T00:00:00Z", "timestamp": 1075593600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Urology Supplements"], "published-print": {"date-parts": [[2004, 2]]}, "DOI": "10.1016/s1569-9056(04)90340-5", "type": "journal-article", "created": {"date-parts": [[2004, 4, 10]], "date-time": "2004-04-10T09:40:04Z", "timestamp": 1081590004000}, "page": "88", "source": "Crossref", "is-referenced-by-count": 1, "title": ["341 Long-term dutasteride therapy results in sustained reductions in total prostate volume in men with symptomatic benign prostatic hyperplasia"], "prefix": "10.1016", "volume": "3", "author": [{"given": "T.", "family": "Tammela", "sequence": "first", "affiliation": []}, {"given": "J.", "family": "Barkin", "sequence": "additional", "affiliation": []}, {"given": "C.", "family": "Roehrborn", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Urology Supplements"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1569905604903405?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1569905604903405?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 14]], "date-time": "2019-02-14T06:20:56Z", "timestamp": 1550125256000}, "score": 49.626858, "issued": {"date-parts": [[2004, 2]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2004, 2]]}, "issue": "2"}, "alternative-id": ["S1569905604903405"], "URL": "http://dx.doi.org/10.1016/s1569-9056(04)90340-5", "ISSN": ["1569-9056"], "issn-type": [{"value": "1569-9056", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T15:38:31Z", "timestamp": 1574177911716}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "1", "license": [{"URL": "http://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1998, 7, 1]], "date-time": "1998-07-01T00:00:00Z", "timestamp": 899251200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Urology"], "published-print": {"date-parts": [[1998, 7]]}, "DOI": "10.1016/s0022-5347(01)63115-x", "type": "journal-article", "created": {"date-parts": [[2006, 1, 17]], "date-time": "2006-01-17T21:48:07Z", "timestamp": 1137534487000}, "page": "272-272", "source": "Crossref", "is-referenced-by-count": 1, "title": ["The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment Among Men With Benign Prostatic Hyperplasia"], "prefix": "10.1097", "volume": "160", "author": [{"given": "J.D.", "family": "McConnell", "sequence": "first", "affiliation": [{"name": "For the Finasteride Long-Term Efficacy and Safety Study Group; University of Texas Southwestern Medical Center, Dallas, Texas, University of Wisconsin Clinical Science Center, Madison, Wisconsin, Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland, Washington University School of Medicine, St. Louis, Missouri, Mayo Clinic, Rochester, Minnesota, University of Connecticut Health Center, Farmington, Connecticut, Queen's University, Kingston, Ontario, Canada, and..."}]}, {"given": "R.", "family": "Bruskewitz", "sequence": "additional", "affiliation": [{"name": "For the Finasteride Long-Term Efficacy and Safety Study Group; University of Texas Southwestern Medical Center, Dallas, Texas, University of Wisconsin Clinical Science Center, Madison, Wisconsin, Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland, Washington University School of Medicine, St. Louis, Missouri, Mayo Clinic, Rochester, Minnesota, University of Connecticut Health Center, Farmington, Connecticut, Queen's University, Kingston, Ontario, Canada, and..."}]}, {"given": "P.", "family": "Walsh", "sequence": "additional", "affiliation": [{"name": "For the Finasteride Long-Term Efficacy and Safety Study Group; University of Texas Southwestern Medical Center, Dallas, Texas, University of Wisconsin Clinical Science Center, Madison, Wisconsin, Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland, Washington University School of Medicine, St. Louis, Missouri, Mayo Clinic, Rochester, Minnesota, University of Connecticut Health Center, Farmington, Connecticut, Queen's University, Kingston, Ontario, Canada, and..."}]}, {"given": "G.", "family": "Andriole", "sequence": "additional", "affiliation": [{"name": "For the Finasteride Long-Term Efficacy and Safety Study Group; University of Texas Southwestern Medical Center, Dallas, Texas, University of Wisconsin Clinical Science Center, Madison, Wisconsin, Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland, Washington University School of Medicine, St. Louis, Missouri, Mayo Clinic, Rochester, Minnesota, University of Connecticut Health Center, Farmington, Connecticut, Queen's University, Kingston, Ontario, Canada, and..."}]}, {"given": "M.", "family": "Lieber", "sequence": "additional", "affiliation": [{"name": "For the Finasteride Long-Term Efficacy and Safety Study Group; University of Texas Southwestern Medical Center, Dallas, Texas, University of Wisconsin Clinical Science Center, Madison, Wisconsin, Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland, Washington University School of Medicine, St. Louis, Missouri, Mayo Clinic, Rochester, Minnesota, University of Connecticut Health Center, Farmington, Connecticut, Queen's University, Kingston, Ontario, Canada, and..."}]}, {"given": "H.L.", "family": "Holtgrewe", "sequence": "additional", "affiliation": [{"name": "For the Finasteride Long-Term Efficacy and Safety Study Group; University of Texas Southwestern Medical Center, Dallas, Texas, University of Wisconsin Clinical Science Center, Madison, Wisconsin, Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland, Washington University School of Medicine, St. Louis, Missouri, Mayo Clinic, Rochester, Minnesota, University of Connecticut Health Center, Farmington, Connecticut, Queen's University, Kingston, Ontario, Canada, and..."}]}, {"given": "P.", "family": "Albertsen", "sequence": "additional", "affiliation": [{"name": "For the Finasteride Long-Term Efficacy and Safety Study Group; University of Texas Southwestern Medical Center, Dallas, Texas, University of Wisconsin Clinical Science Center, Madison, Wisconsin, Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland, Washington University School of Medicine, St. Louis, Missouri, Mayo Clinic, Rochester, Minnesota, University of Connecticut Health Center, Farmington, Connecticut, Queen's University, Kingston, Ontario, Canada, and..."}]}, {"given": "C.G.", "family": "Roehrborn", "sequence": "additional", "affiliation": [{"name": "For the Finasteride Long-Term Efficacy and Safety Study Group; University of Texas Southwestern Medical Center, Dallas, Texas, University of Wisconsin Clinical Science Center, Madison, Wisconsin, Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland, Washington University School of Medicine, St. Louis, Missouri, Mayo Clinic, Rochester, Minnesota, University of Connecticut Health Center, Farmington, Connecticut, Queen's University, Kingston, Ontario, Canada, and..."}]}, {"given": "J.C.", "family": "Nickel", "sequence": "additional", "affiliation": [{"name": "For the Finasteride Long-Term Efficacy and Safety Study Group; University of Texas Southwestern Medical Center, Dallas, Texas, University of Wisconsin Clinical Science Center, Madison, Wisconsin, Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland, Washington University School of Medicine, St. Louis, Missouri, Mayo Clinic, Rochester, Minnesota, University of Connecticut Health Center, Farmington, Connecticut, Queen's University, Kingston, Ontario, Canada, and..."}]}, {"given": "D.Z.", "family": "Wang", "sequence": "additional", "affiliation": [{"name": "For the Finasteride Long-Term Efficacy and Safety Study Group; University of Texas Southwestern Medical Center, Dallas, Texas, University of Wisconsin Clinical Science Center, Madison, Wisconsin, Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland, Washington University School of Medicine, St. Louis, Missouri, Mayo Clinic, Rochester, Minnesota, University of Connecticut Health Center, Farmington, Connecticut, Queen's University, Kingston, Ontario, Canada, and..."}]}, {"given": "A.M.", "family": "Taylor", "sequence": "additional", "affiliation": [{"name": "For the Finasteride Long-Term Efficacy and Safety Study Group; University of Texas Southwestern Medical Center, Dallas, Texas, University of Wisconsin Clinical Science Center, Madison, Wisconsin, Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland, Washington University School of Medicine, St. Louis, Missouri, Mayo Clinic, Rochester, Minnesota, University of Connecticut Health Center, Farmington, Connecticut, Queen's University, Kingston, Ontario, Canada, and..."}]}, {"given": "J.", "family": "Waldstreicher", "sequence": "additional", "affiliation": [{"name": "For the Finasteride Long-Term Efficacy and Safety Study Group; University of Texas Southwestern Medical Center, Dallas, Texas, University of Wisconsin Clinical Science Center, Madison, Wisconsin, Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland, Washington University School of Medicine, St. Louis, Missouri, Mayo Clinic, Rochester, Minnesota, University of Connecticut Health Center, Farmington, Connecticut, Queen's University, Kingston, Ontario, Canada, and..."}]}], "member": "276", "container-title": ["Journal of Urology"], "language": "en", "link": [{"URL": "http://api.elsevier.com/content/article/PII:S002253470163115X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://api.elsevier.com/content/article/PII:S002253470163115X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 6, 17]], "date-time": "2019-06-17T16:44:48Z", "timestamp": 1560789888000}, "score": 49.19505, "issued": {"date-parts": [[1998, 7]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1998, 7]]}, "issue": "1"}, "alternative-id": ["10.1016/S0022-5347(01)63115-X"], "URL": "http://dx.doi.org/10.1016/s0022-5347(01)63115-x", "ISSN": ["0022-5347", "1527-3792"], "issn-type": [{"value": "0022-5347", "type": "print"}, {"value": "1527-3792", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T21:12:16Z", "timestamp": 1575321136413}, "reference-count": 51, "publisher": "Springer Science and Business Media LLC", "issue": "S3", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2008, 11, 10]], "date-time": "2008-11-10T00:00:00Z", "timestamp": 1226275200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Int J Impot Res"], "published-print": {"date-parts": [[2008, 12]]}, "DOI": "10.1038/ijir.2008.53", "type": "journal-article", "created": {"date-parts": [[2008, 11, 10]], "date-time": "2008-11-10T17:17:05Z", "timestamp": 1226337425000}, "page": "S19-S26", "source": "Crossref", "is-referenced-by-count": 20, "title": ["The utility of serum prostatic-specific antigen in the management of men with benign prostatic hyperplasia"], "prefix": "10.1038", "volume": "20", "author": [{"given": "C G", "family": "Roehrborn", "sequence": "first", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2008, 11, 10]]}, "reference": [{"key": "BFijir200853_CR1", "author": "C Roehrborn", "first-page": "1297", "year": "2002", "unstructured": "Roehrborn C, McConnell J . Etiology, pathophysiology, epidemiology and natural history of benign prostatic hyperplasia. In: Walsh P, Retik A, Vaughan E, Wein A (eds). Campbell's Urology, 8th edn. Saunders: Philadelphia, 2002, pp 1297\u20131336.", "volume-title": "Campbell's Urology"}, {"key": "BFijir200853_CR2", "doi-asserted-by": "publisher", "first-page": "548", "DOI": "10.1016/S0090-4295(97)00031-9", "volume": "49", "author": "CG Roehrborn", "year": "1997", "unstructured": "Roehrborn CG, Girman CJ, Rhodes T, Hanson KA, Collins GN, Sech SM et al. Correlation between prostate size estimated by digital rectal examination and measured by transrectal ultrasound. Urology 1997; 49: 548\u2013557.", "journal-title": "Urology"}, {"key": "BFijir200853_CR3", "doi-asserted-by": "publisher", "first-page": "2239", "DOI": "10.1056/NEJMoa031918", "volume": "350", "author": "IM Thompson", "year": "2004", "unstructured": "Thompson IM, Pauler DK, Goodman PJ, Tangen CM, Lucia MS, Parnes HL et al. Prevalence of prostate cancer among men with a prostate-specific antigen level &lt;or=4.0\u2009ng per milliliter. N Engl J Med 2004; 350: 2239\u20132246.", "journal-title": "N Engl J Med"}, {"key": "BFijir200853_CR4", "doi-asserted-by": "publisher", "first-page": "335", "DOI": "10.1002/pros.20293", "volume": "66", "author": "JL Bosch", "year": "2006", "unstructured": "Bosch JL, Tilling K, Bohnen AM, Donovan JL . Establishing normal reference ranges for PSA change with age in a population-based study: the Krimpen study. Prostate 2006; 66: 335\u2013343.", "journal-title": "Prostate"}, {"key": "BFijir200853_CR5", "doi-asserted-by": "publisher", "first-page": "146", "DOI": "10.1016/S0022-5347(05)67991-8", "volume": "163", "author": "IJ Powell", "year": "2000", "unstructured": "Powell IJ, Banerjee M, Novallo M, Sakr W, Grignon D, Wood DP et al. Should the age specific prostate specific antigen cutoff for prostate biopsy be higher for black than for white men older than 50 years? J Urol 2000; 163: 146\u2013148; discussion 148\u2013149.", "journal-title": "J Urol"}, {"key": "BFijir200853_CR6", "first-page": "475", "volume": "11", "author": "EP DeAntoni", "year": "1997", "unstructured": "DeAntoni EP . Age-specific reference ranges for PSA in the detection of prostate cancer. Oncology (Williston Park) 1997; 11: 475\u2013482, 485; discussion 485\u2013476, 489.", "journal-title": "Oncology (Williston Park)"}, {"key": "BFijir200853_CR7", "doi-asserted-by": "publisher", "first-page": "234", "DOI": "10.1016/S0090-4295(96)00091-X", "volume": "48", "author": "EP DeAntoni", "year": "1996", "unstructured": "DeAntoni EP, Crawford ED, Oesterling JE, Ross CA, Berger ER, McLeod DG et al. Age- and race-specific reference ranges for prostate-specific antigen from a large community-based study. Urology 1996; 48: 234\u2013239.", "journal-title": "Urology"}, {"key": "BFijir200853_CR8", "doi-asserted-by": "publisher", "first-page": "860", "DOI": "10.1001/jama.1993.03510070082041", "volume": "270", "author": "JE Oesterling", "year": "1993", "unstructured": "Oesterling JE, Jacobsen SJ, Chute CG, Guess HA, Girman CJ, Panser LA et al. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. JAMA 1993; 270: 860\u2013864.", "journal-title": "JAMA"}, {"key": "BFijir200853_CR9", "doi-asserted-by": "publisher", "first-page": "581", "DOI": "10.1016/S0090-4295(98)00655-4", "volume": "53", "author": "CG Roehrborn", "year": "1999", "unstructured": "Roehrborn CG, Boyle P, Gould AL, Waldstreicher J . Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia. Urology 1999; 53: 581\u2013589.", "journal-title": "Urology"}, {"key": "BFijir200853_CR10", "doi-asserted-by": "publisher", "first-page": "154", "DOI": "10.1080/00365590510007685", "volume": "39", "author": "H Hedelin", "year": "2005", "unstructured": "Hedelin H, Johansson N, Stroberg P . Relationship between benign prostatic hyperplasia and lower urinary tract symptoms and correlation between prostate volume and serum prostate-specific antigen in clinical routine. Scand J Urol Nephrol 2005; 39: 154\u2013159.", "journal-title": "Scand J Urol Nephrol"}, {"key": "BFijir200853_CR11", "doi-asserted-by": "publisher", "first-page": "315", "DOI": "10.1002/1097-0045(20001201)45:4<315::AID-PROS5>3.0.CO;2-2", "volume": "45", "author": "DA Hochberg", "year": "2000", "unstructured": "Hochberg DA, Armenakas NA, Fracchia JA . Relationship of prostate-specific antigen and prostate volume in patients with biopsy proven benign prostatic hyperplasia. Prostate 2000; 45: 315\u2013319.", "journal-title": "Prostate"}, {"key": "BFijir200853_CR12", "doi-asserted-by": "publisher", "first-page": "111", "DOI": "10.1097/00005392-199501000-00038", "volume": "153", "author": "PG Hammerer", "year": "1995", "unstructured": "Hammerer PG, McNeal JE, Stamey TA . Correlation between serum prostate specific antigen levels and the volume of the individual glandular zones of the human prostate. J Urol 1995; 153: 111\u2013114.", "journal-title": "J Urol"}, {"key": "BFijir200853_CR13", "first-page": "666", "volume": "94", "author": "HJ Yu", "year": "1995", "unstructured": "Yu HJ, Chiang GJ, Chiu TY, Lai MK . Relationship between serum prostate specific antigen concentration and prostate volume. J Formos Med Assoc 1995; 94: 666\u2013670.", "journal-title": "J Formos Med Assoc"}, {"key": "BFijir200853_CR14", "doi-asserted-by": "publisher", "first-page": "241", "DOI": "10.1002/pros.2990270503", "volume": "27", "author": "JL Bosch", "year": "1995", "unstructured": "Bosch JL, Hop WC, Bangma CH, Kirkels WJ, Schroder FH . Prostate specific antigen in a community-based sample of men without prostate cancer: correlations with prostate volume, age, body mass index, and symptoms of prostatism. Prostate 1995; 27: 241\u2013249.", "journal-title": "Prostate"}, {"key": "BFijir200853_CR15", "doi-asserted-by": "publisher", "first-page": "1174", "DOI": "10.1016/S0022-5347(01)61621-5", "volume": "161", "author": "T Rhodes", "year": "1999", "unstructured": "Rhodes T, Girman CJ, Jacobsen SJ, Roberts RO, Guess HA, Lieber MM . Longitudinal prostate growth rates during 5 years in randomly selected community men 40\u201379 years old. J Urol 1999; 161: 1174\u20131179.", "journal-title": "J Urol"}, {"key": "BFijir200853_CR16", "doi-asserted-by": "publisher", "first-page": "348", "DOI": "10.1016/S0090-4295(02)02265-3", "volume": "61", "author": "SJ Jacobsen", "year": "2003", "unstructured": "Jacobsen SJ, Jacobson DJ, Rohe DE, Girman CJ, Roberts RO, Lieber MM . Frequency of sexual activity and prostatic health: fact or fairy tale? Urology 2003; 61: 348\u2013353.", "journal-title": "Urology"}, {"key": "BFijir200853_CR17", "doi-asserted-by": "publisher", "first-page": "2385", "DOI": "10.1056/NEJMoa030656", "volume": "349", "author": "J McConnell", "year": "2003", "unstructured": "McConnell J, Roehrborn C, Bautista O, Andriole Jr GL, Dixon C, Kusek J et al. The long-term effects of doxazosin, finasteride and the combination on the clinical progression of benign prostatic hyperplasia. NEJM 2003; 349: 2385\u20132396.", "journal-title": "NEJM"}, {"key": "BFijir200853_CR18", "unstructured": "Roehrborn CG, McConnell JD, Bonilla J, Rosenblatt S, Hudson PB, Malek GH et al. Serum prostate specific antigen and prostate volume predict long-term changes in symptom and flow rate: results of a four-year randomized trial comparing finasteride versus placebo. Urology 1999.", "DOI": "10.1016/S0090-4295(99)00232-0", "doi-asserted-by": "crossref"}, {"key": "BFijir200853_CR19", "doi-asserted-by": "publisher", "first-page": "1144", "DOI": "10.1016/j.urology.2004.08.049", "volume": "64", "author": "B Djavan", "year": "2004", "unstructured": "Djavan B, Fong YK, Harik M, Milani S, Reissigl A, Chaudry A et al. Longitudinal study of men with mild symptoms of bladder outlet obstruction treated with watchful waiting for four years. Urology 2004; 64: 1144\u20131148.", "journal-title": "Urology"}, {"key": "BFijir200853_CR20", "doi-asserted-by": "publisher", "first-page": "1422", "DOI": "10.1016/S0022-5347(05)00708-1", "volume": "175", "author": "ED Crawford", "year": "2006", "unstructured": "Crawford ED, Wilson SS, McConnell JD, Slawin KM, Lieber MC, Smith JA et al. Baseline factors as predictors of clinical progression of benign prostatic hyperplasia in men treated with placebo. J Urol 2006; 175: 1422\u20131426; discussion 1426\u20131427.", "journal-title": "J Urol"}, {"key": "BFijir200853_CR21", "doi-asserted-by": "publisher", "first-page": "670", "DOI": "10.1016/S0090-4295(99)00209-5", "volume": "54", "author": "R Bruskewitz", "year": "1999", "unstructured": "Bruskewitz R, Girman CJ, Fowler J, Rigby OF, Sullivan M, Bracken RB et al. Effect of finasteride on bother and other health-related quality of life aspects associated with benign prostatic hyperplasia. PLESS Study Group. Proscar Long-term Efficacy and Safety Study. Urology 1999; 54: 670\u2013678.", "journal-title": "Urology"}, {"key": "BFijir200853_CR22", "doi-asserted-by": "publisher", "first-page": "473", "DOI": "10.1016/S0090-4295(98)00654-2", "volume": "53", "author": "CG Roehrborn", "year": "1999", "unstructured": "Roehrborn CG, McConnell JD, Lieber M, Kaplan S, Geller J, Malek GH et al. Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. PLESS Study Group. Urology 1999; 53: 473\u2013480.", "journal-title": "Urology"}, {"key": "BFijir200853_CR23", "doi-asserted-by": "publisher", "first-page": "709", "DOI": "10.1016/j.urology.2004.01.001", "volume": "63", "author": "CG Roehrborn", "year": "2004", "unstructured": "Roehrborn CG, Marks LS, Fenter T, Freedman S, Tuttle J, Gittleman M et al. Efficacy and safety of dutasteride in the four-year treatment of men with benign prostatic hyperplasia. Urology 2004; 63: 709\u2013715.", "journal-title": "Urology"}, {"key": "BFijir200853_CR24", "doi-asserted-by": "publisher", "first-page": "434", "DOI": "10.1016/S0090-4295(02)01905-2", "volume": "60", "author": "CG Roehrborn", "year": "2002", "unstructured": "Roehrborn CG, Boyle P, Nickel JC, Hoefner K, Andriole G . Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia. Urology 2002; 60: 434\u2013441.", "journal-title": "Urology"}, {"key": "BFijir200853_CR25", "doi-asserted-by": "publisher", "first-page": "1301", "DOI": "10.1016/S0022-5347(05)68271-7", "volume": "162", "author": "SJ Jacobsen", "year": "1999", "unstructured": "Jacobsen SJ, Jacobson DJ, Girman CJ, Roberts RO, Rhodes T, Guess HA et al. Treatment for benign prostatic hyperplasia among community dwelling men: the Olmsted County study of urinary symptoms and health status. J Urol 1999; 162: 1301\u20131306.", "journal-title": "J Urol"}, {"key": "BFijir200853_CR26", "doi-asserted-by": "publisher", "first-page": "610", "DOI": "10.1016/S0090-4295(00)00724-X", "volume": "56", "author": "S Kaplan", "year": "2000", "unstructured": "Kaplan S, Garvin D, Gilhooly P, Koppel M, Labasky R, Milsten R et al. Impact of baseline symptom severity on future risk of benign prostatic hyperplasia-related outcomes and long-term response to finasteride. The Pless Study Group. Urology 2000; 56: 610\u2013616.", "journal-title": "Urology"}, {"key": "BFijir200853_CR27", "doi-asserted-by": "publisher", "first-page": "1073", "DOI": "10.1016/S0090-4295(01)00985-2", "volume": "57", "author": "SA Kaplan", "year": "2001", "unstructured": "Kaplan SA, Holtgrewe HL, Bruskewitz R, Saltzman B, Mobley D, Narayan P et al. Comparison of the efficacy and safety of finasteride in older versus younger men with benign prostatic hyperplasia. Urology 2001; 57: 1073\u20131077.", "journal-title": "Urology"}, {"issue": "Suppl 4", "key": "BFijir200853_CR28", "doi-asserted-by": "publisher", "first-page": "29", "DOI": "10.1111/j.1464-410X.2005.05485.x", "volume": "95", "author": "S Milani", "year": "2005", "unstructured": "Milani S, Djavan B . Lower urinary tract symptoms suggestive of benign prostatic hyperplasia: latest update on alpha-adrenoceptor antagonists. BJU Int 2005; 95 (Suppl 4): 29\u201336.", "journal-title": "BJU Int"}, {"key": "BFijir200853_CR29", "doi-asserted-by": "publisher", "first-page": "1029", "DOI": "10.1097/01.ju.0000097026.43866.cc", "volume": "171", "author": "CG Roehrborn", "year": "2004", "unstructured": "Roehrborn CG, Schwinn DA . Alpha1-adrenergic receptors and their inhibitors in lower urinary tract symptoms and benign prostatic hyperplasia. J Urol 2004; 171: 1029\u20131035.", "journal-title": "J Urol"}, {"key": "BFijir200853_CR30", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1016/S0302-2838(02)00210-5", "volume": "42", "author": "CG Roehrborn", "year": "2002", "unstructured": "Roehrborn CG, McConnell JD, Saltzman B, Bergner D, Gray T, Narayan P et al. Storage (irritative) and voiding (obstructive) symptoms as predictors of benign prostatic hyperplasia progression and related outcomes. Eur Urol 2002; 42: 1\u20136.", "journal-title": "Eur Urol"}, {"key": "BFijir200853_CR31", "doi-asserted-by": "publisher", "first-page": "257", "DOI": "10.1046/j.1464-410X.2003.04309.x", "volume": "92", "author": "CG Roehrborn", "year": "2003", "unstructured": "Roehrborn CG, Van Kerrebroeck P, Nordling J . Safety and efficacy of alfuzosin 10\u2009mg once-daily in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a pooled analysis of three double-blind, placebo-controlled studies. BJU Int 2003; 92: 257\u2013261.", "journal-title": "BJU Int"}, {"key": "BFijir200853_CR32", "doi-asserted-by": "publisher", "first-page": "121", "DOI": "10.1038/sj.pcan.4500849", "volume": "9", "author": "CG Roehrborn", "year": "2006", "unstructured": "Roehrborn CG . Three months\u2019 treatment with the alpha1-blocker alfuzosin does not affect total or transition zone volume of the prostate. Prostate Cancer Prostatic dis 2006; 9: 121\u2013125.", "journal-title": "Prostate Cancer Prostatic dis"}, {"key": "BFijir200853_CR33", "doi-asserted-by": "publisher", "first-page": "533", "DOI": "10.1056/NEJM199608223350801", "volume": "335", "author": "H Lepor", "year": "1996", "unstructured": "Lepor H, Williford WO, Barry MJ, Brawer MK, Dixon CM, Gormley G et al. The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group. N Engl J Med 1996; 335: 533\u2013539.", "journal-title": "N Engl J Med"}, {"issue": "Suppl 4", "key": "BFijir200853_CR34", "first-page": "364", "volume": "169", "author": "CG Roehrborn", "year": "2003", "unstructured": "Roehrborn CG, McConnell JDM et al. Baseline prostate volume and serum PSA predict rate of prostate growth: analysis from the MTOPS data. J Urol 2003; 169 (Suppl 4): 364.", "journal-title": "J Urol"}, {"key": "BFijir200853_CR35", "doi-asserted-by": "publisher", "first-page": "791", "DOI": "10.1016/S0090-4295(02)02548-7", "volume": "61", "author": "FC Lowe", "year": "2003", "unstructured": "Lowe FC, McConnell JD, Hudson PB, Romas NA, Boake R, Lieber M et al. Long-term 6-year experience with finasteride in patients with benign prostatic hyperplasia. Urology 2003; 61: 791\u2013796.", "journal-title": "Urology"}, {"key": "BFijir200853_CR36", "doi-asserted-by": "publisher", "first-page": "717", "DOI": "10.1016/S0090-4295(01)01344-9", "volume": "58", "author": "P Boyle", "year": "2001", "unstructured": "Boyle P, Robertson C, Manski R, Padley RJ, Roehrborn CG . Meta-analysis of randomized trials of terazosin in the treatment of benign prostatic hyperplasia. Urology 2001; 58: 717\u2013722.", "journal-title": "Urology"}, {"key": "BFijir200853_CR37", "doi-asserted-by": "publisher", "first-page": "734", "DOI": "10.1111/j.1464-410X.2006.06110.x", "volume": "97", "author": "CG Roehrborn", "year": "2006", "unstructured": "Roehrborn CG . Alfuzosin 10\u2009mg once daily prevents overall clinical progression of benign prostatic hyperplasia but not acute urinary retention: results of a 2-year placebo-controlled study. BJU Int 2006; 97: 734\u2013741.", "journal-title": "BJU Int"}, {"key": "BFijir200853_CR38", "doi-asserted-by": "publisher", "first-page": "398", "DOI": "10.1016/S0090-4295(96)00353-6", "volume": "48", "author": "P Boyle", "year": "1996", "unstructured": "Boyle P, Gould AL, Roehrborn CG . Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: meta-analysis of randomized clinical trials. Urology 1996; 48: 398\u2013405.", "journal-title": "Urology"}, {"key": "BFijir200853_CR39", "doi-asserted-by": "publisher", "first-page": "134A", "DOI": "10.1016/S0022-5347(01)65306-0", "volume": "157", "author": "P Boyle", "year": "1997", "unstructured": "Boyle P, Roehrborn C, Gould L . Baseline serum PSA levels predict degree of symptom improvement following therapy of BPH with finasteride. J Urol 1997; 157: 134A.", "journal-title": "J Urol"}, {"key": "BFijir200853_CR40", "doi-asserted-by": "publisher", "first-page": "2387", "DOI": "10.1056/NEJMoa030656", "volume": "349", "author": "JD McConnell", "year": "2003", "unstructured": "McConnell JD, Roehrborn CG, Bautista OM, Andriole Jr GL, Dixon CM, Kusek JW et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 2003; 349: 2387\u20132398.", "journal-title": "N Engl J Med"}, {"key": "BFijir200853_CR41", "doi-asserted-by": "publisher", "first-page": "620", "DOI": "10.1016/j.eururo.2003.09.012", "volume": "45", "author": "P Boyle", "year": "2004", "unstructured": "Boyle P, Roehrborn C, Harkaway R, Logie J, de la Rosette J, Emberton M . 5-Alpha reductase inhibition provides superior benefits to alpha blockade by preventing AUR and BPH-related surgery. Eur Urol 2004; 45: 620\u2013626; discussion 626\u2013627.", "journal-title": "Eur Urol"}, {"key": "BFijir200853_CR42", "doi-asserted-by": "publisher", "first-page": "528", "DOI": "10.1159/000020189", "volume": "37", "author": "C Roehrborn", "year": "2000", "unstructured": "Roehrborn C, Bruskewitz R, Nickel GC, Glickman S, Cox C, Anderson R et al. Urinary retention in patients with BPH treated with finasteride or placebo over four years: characterization of patients and ultimate outcomes. The PLESS Study Group. Eur Urol 2000; 37: 528\u2013536.", "journal-title": "Eur Urol"}, {"key": "BFijir200853_CR43", "doi-asserted-by": "publisher", "first-page": "556", "DOI": "10.1016/S0090-4295(97)00302-6", "volume": "50", "author": "CG Roehrborn", "year": "1997", "unstructured": "Roehrborn CG, Oesterling JE, Olson PJ, Padley RJ, Group HI . Serial prostate-specific antigen measurements in men with clinically benign prostatic hyperplasia during a 12-months placebo-controlled study with terazosin. Urology 1997; 50: 556\u2013561.", "journal-title": "Urology"}, {"key": "BFijir200853_CR44", "doi-asserted-by": "publisher", "first-page": "119", "DOI": "10.1016/S0090-4295(02)02114-3", "volume": "61", "author": "RS Kirby", "year": "2003", "unstructured": "Kirby RS, Roehrborn C, Boyle P, Bartsch G, Jardin A, Cary MM et al. Efficacy and tolerability of doxazosin and finasteride, alone or in combination, in treatment of symptomatic benign prostatic hyperplasia: the Prospective European Doxazosin and Combination Therapy (PREDICT) trial. Urology 2003; 61: 119\u2013126.", "journal-title": "Urology"}, {"issue": "Suppl 1", "key": "BFijir200853_CR45", "first-page": "107", "volume": "1", "author": "C Roehrborn", "year": "2002", "unstructured": "Roehrborn C, Andriole G, Boyle P, Hofner K . Effect of the dual 5 alpha reductase inhibitor dutasteride on endocrine parameters and prostate volume. Eur Urol 2002; 1 (Suppl 1): 107.", "journal-title": "Eur Urol"}, {"key": "BFijir200853_CR46", "doi-asserted-by": "publisher", "first-page": "1185", "DOI": "10.1056/NEJM199210223271701", "volume": "327", "author": "GJ Gormley", "year": "1992", "unstructured": "Gormley GJ, Stoner E, Bruskewitz RC, Imperato-McGinley J, Walsh PC, McConnell JD et al. The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group. N Engl J Med 1992; 327: 1185\u20131191.", "journal-title": "N Engl J Med"}, {"key": "BFijir200853_CR47", "doi-asserted-by": "publisher", "first-page": "234", "DOI": "10.1002/(SICI)1097-0045(19990601)39:4<234::AID-PROS3>3.0.CO;2-4", "volume": "39", "author": "MK Brawer", "year": "1999", "unstructured": "Brawer MK, Lin DW, Williford WO, Jones K, Lepor H . Effect of finasteride and/or terazosin on serum PSA: results of VA Cooperative Study #359. Prostate 1999; 39: 234\u2013239.", "journal-title": "Prostate"}, {"key": "BFijir200853_CR48", "doi-asserted-by": "publisher", "first-page": "1128", "DOI": "10.1093/jnci/djj307", "volume": "98", "author": "IM Thompson", "year": "2006", "unstructured": "Thompson IM, Chi C, Ankerst DP, Goodman PJ, Tangen CM, Lippman SM et al. Effect of finasteride on the sensitivity of PSA for detecting prostate cancer. J Natl Cancer Inst 2006; 98: 1128\u20131133.", "journal-title": "J Natl Cancer Inst"}, {"key": "BFijir200853_CR49", "doi-asserted-by": "publisher", "first-page": "537", "DOI": "10.1016/j.urology.2004.04.084", "volume": "64", "author": "GL Andriole", "year": "2004", "unstructured": "Andriole GL, Roehrborn C, Schulman C, Slawin KM, Somerville M, Rittmaster RS . Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia. Urology 2004; 64: 537\u2013541; discussion 542\u2013533.", "journal-title": "Urology"}, {"key": "BFijir200853_CR50", "doi-asserted-by": "publisher", "first-page": "1657", "DOI": "10.1016/S0022-5347(05)00984-5", "volume": "175", "author": "GL Andriole", "year": "2006", "unstructured": "Andriole GL, Marberger M, Roehrborn CG . Clinical usefulness of serum prostate specific antigen for the detection of prostate cancer is preserved in men receiving the dual 5 alpha-reductase inhibitor dutasteride. J Urol 2006; 175: 1657\u20131662.", "journal-title": "J Urol"}, {"key": "BFijir200853_CR51", "doi-asserted-by": "publisher", "first-page": "868", "DOI": "10.1016/j.juro.2006.04.024", "volume": "176", "author": "LS Marks", "year": "2006", "unstructured": "Marks LS, Andriole GL, Fitzpatrick JM, Schulman CC, Roehrborn CG . The interpretation of serum prostate specific antigen in men receiving 5alpha-reductase inhibitors: a review and clinical recommendations. J Urol 2006; 176: 868\u2013874.", "journal-title": "J Urol"}], "container-title": ["International Journal of Impotence Research"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/ijir200853.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/ijir200853", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/ijir200853.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 24]], "date-time": "2019-04-24T06:19:41Z", "timestamp": 1556086781000}, "score": 48.61493, "issued": {"date-parts": [[2008, 11, 10]]}, "references-count": 51, "journal-issue": {"published-print": {"date-parts": [[2008, 12]]}, "issue": "S3"}, "alternative-id": ["BFijir200853"], "URL": "http://dx.doi.org/10.1038/ijir.2008.53", "relation": {"cites": []}, "ISSN": ["0955-9930", "1476-5489"], "issn-type": [{"value": "0955-9930", "type": "print"}, {"value": "1476-5489", "type": "electronic"}], "subject": ["Urology"]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T19:29:52Z", "timestamp": 1574364592552}, "reference-count": 1, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2007, 1, 1]], "date-time": "2007-01-01T00:00:00Z", "timestamp": 1167609600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Yearbook of Urology"], "published-print": {"date-parts": [[2007, 1]]}, "DOI": "10.1016/s0084-4071(08)70079-4", "type": "journal-article", "created": {"date-parts": [[2008, 4, 17]], "date-time": "2008-04-17T21:16:36Z", "timestamp": 1208466996000}, "page": "101-104", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Tadalafil Relieves Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia"], "prefix": "10.1016", "volume": "2007", "author": [{"given": "C.G.", "family": "Roehrborn", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Yearbook of Urology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0084407108700794?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0084407108700794?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 29]], "date-time": "2018-12-29T22:28:35Z", "timestamp": 1546122515000}, "score": 48.5007, "issued": {"date-parts": [[2007, 1]]}, "references-count": 1, "alternative-id": ["S0084407108700794"], "URL": "http://dx.doi.org/10.1016/s0084-4071(08)70079-4", "ISSN": ["0084-4071"], "issn-type": [{"value": "0084-4071", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T23:32:54Z", "timestamp": 1574465574141}, "reference-count": 1, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2008, 1, 1]], "date-time": "2008-01-01T00:00:00Z", "timestamp": 1199145600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Yearbook of Urology"], "published-print": {"date-parts": [[2008, 1]]}, "DOI": "10.1016/s0084-4071(08)79002-x", "type": "journal-article", "created": {"date-parts": [[2012, 4, 2]], "date-time": "2012-04-02T18:57:46Z", "timestamp": 1333393066000}, "page": "82-83", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Physical Activity, Benign Prostatic Hyperplasia, and Lower Urinary Tract Symptoms"], "prefix": "10.1016", "volume": "2008", "author": [{"given": "C.G.", "family": "Roehrborn", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Yearbook of Urology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S008440710879002X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S008440710879002X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 11, 24]], "date-time": "2018-11-24T12:58:10Z", "timestamp": 1543064290000}, "score": 48.5007, "issued": {"date-parts": [[2008, 1]]}, "references-count": 1, "alternative-id": ["S008440710879002X"], "URL": "http://dx.doi.org/10.1016/s0084-4071(08)79002-x", "ISSN": ["0084-4071"], "issn-type": [{"value": "0084-4071", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T18:37:22Z", "timestamp": 1574707042902}, "reference-count": 0, "publisher": "Canadian Urological Association Journal", "issue": "5-S2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["CUAJ"], "abstract": "<jats:p>Lower urinary tract symptoms (LUTS) are very common in men,with incidence increasing with age. Several clinical practice guidelines are available as decision-making aids for men with LUTS and the recommendations are based on the presumed etiology of the symptoms (due to obstruction, overactive bladder or a combination of the two). This review presents the various pharmacologic treatment options and summarizes key clinical trial data supporting their use.</jats:p>", "DOI": "10.5489/cuaj.1467", "type": "journal-article", "created": {"date-parts": [[2016, 10, 11]], "date-time": "2016-10-11T15:29:07Z", "timestamp": 1476199747000}, "page": "130", "source": "Crossref", "is-referenced-by-count": 4, "title": ["Benign prostatic hyperplasia and lower urinary tract symptom guidelines"], "prefix": "10.5489", "volume": "6", "author": [{"given": "Claus", "family": "Roehrborn", "sequence": "first", "affiliation": []}], "member": "3456", "published-online": {"date-parts": [[2013, 10, 1]]}, "container-title": ["Canadian Urological Association Journal"], "link": [{"URL": "http://cuaj.ca/index.php/journal/article/viewFile/1467/1231", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://cuaj.ca/index.php/journal/article/viewFile/1467/1231", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 10, 11]], "date-time": "2016-10-11T15:29:39Z", "timestamp": 1476199779000}, "score": 48.5007, "issued": {"date-parts": [[2013, 10, 1]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2013, 6, 19]]}, "issue": "5-S2"}, "URL": "http://dx.doi.org/10.5489/cuaj.1467", "ISSN": ["1920-1214"], "issn-type": [{"value": "1920-1214", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T23:32:53Z", "timestamp": 1574465573959}, "reference-count": 2, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2008, 1, 1]], "date-time": "2008-01-01T00:00:00Z", "timestamp": 1199145600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Yearbook of Urology"], "published-print": {"date-parts": [[2008, 1]]}, "DOI": "10.1016/s0084-4071(08)79112-7", "type": "journal-article", "created": {"date-parts": [[2012, 4, 2]], "date-time": "2012-04-02T18:57:05Z", "timestamp": 1333393025000}, "page": "73-74", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Lipids, lipoproteins and the risk of benign prostatic hyperplasia in community-dwelling men"], "prefix": "10.1016", "volume": "2008", "author": [{"given": "C.G.", "family": "Roehrborn", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Yearbook of Urology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0084407108791127?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0084407108791127?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 11, 24]], "date-time": "2018-11-24T12:58:24Z", "timestamp": 1543064304000}, "score": 48.185017, "issued": {"date-parts": [[2008, 1]]}, "references-count": 2, "alternative-id": ["S0084407108791127"], "URL": "http://dx.doi.org/10.1016/s0084-4071(08)79112-7", "ISSN": ["0084-4071"], "issn-type": [{"value": "0084-4071", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T09:12:34Z", "timestamp": 1575105154917}, "reference-count": 17, "publisher": "Elsevier BV", "issue": "5", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2003, 11, 1]], "date-time": "2003-11-01T00:00:00Z", "timestamp": 1067644800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Urology"], "published-print": {"date-parts": [[2003, 11]]}, "DOI": "10.1016/s0090-4295(03)00661-7", "type": "journal-article", "created": {"date-parts": [[2003, 11, 14]], "date-time": "2003-11-14T13:19:23Z", "timestamp": 1068815963000}, "page": "894-899", "source": "Crossref", "is-referenced-by-count": 32, "title": ["Effects of finasteride on serum testosterone and body mass index in men with benign prostatic hyperplasia"], "prefix": "10.1016", "volume": "62", "author": [{"given": "Claus G", "family": "Roehrborn", "sequence": "first", "affiliation": []}, {"given": "Michael", "family": "Lee", "sequence": "additional", "affiliation": []}, {"given": "Alan", "family": "Meehan", "sequence": "additional", "affiliation": []}, {"given": "Joanne", "family": "Waldstreicher", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Urology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0090429503006617?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0090429503006617?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 17]], "date-time": "2019-02-17T02:58:35Z", "timestamp": 1550372315000}, "score": 47.88719, "issued": {"date-parts": [[2003, 11]]}, "references-count": 17, "journal-issue": {"published-print": {"date-parts": [[2003, 11]]}, "issue": "5"}, "alternative-id": ["S0090429503006617"], "URL": "http://dx.doi.org/10.1016/s0090-4295(03)00661-7", "ISSN": ["0090-4295"], "issn-type": [{"value": "0090-4295", "type": "print"}], "subject": ["Urology"]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T13:38:47Z", "timestamp": 1574170727975}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2003, 2, 1]], "date-time": "2003-02-01T00:00:00Z", "timestamp": 1044057600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Urology Supplements"], "published-print": {"date-parts": [[2003, 2]]}, "DOI": "10.1016/s1569-9056(03)80102-1", "type": "journal-article", "created": {"date-parts": [[2003, 8, 8]], "date-time": "2003-08-08T01:06:34Z", "timestamp": 1060304794000}, "page": "26", "source": "Crossref", "is-referenced-by-count": 3, "title": ["Risk factors for acute urinary retention in men with benign prostatic hyperplasia"], "prefix": "10.1016", "volume": "2", "author": [{"given": "P.", "family": "Boyle", "sequence": "first", "affiliation": []}, {"given": "C.", "family": "Robertson", "sequence": "additional", "affiliation": []}, {"given": "T.", "family": "Wilson", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "D'Omofrio", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Benichou", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Urology Supplements"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1569905603801021?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1569905603801021?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 3, 15]], "date-time": "2019-03-15T05:27:57Z", "timestamp": 1552627677000}, "score": 47.53541, "issued": {"date-parts": [[2003, 2]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2003, 2]]}, "issue": "1"}, "alternative-id": ["S1569905603801021"], "URL": "http://dx.doi.org/10.1016/s1569-9056(03)80102-1", "ISSN": ["1569-9056"], "issn-type": [{"value": "1569-9056", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T22:48:43Z", "timestamp": 1574117323681}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2004, 2, 1]], "date-time": "2004-02-01T00:00:00Z", "timestamp": 1075593600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Urology Supplements"], "published-print": {"date-parts": [[2004, 2]]}, "DOI": "10.1016/s1569-9056(04)90228-x", "type": "journal-article", "created": {"date-parts": [[2004, 4, 10]], "date-time": "2004-04-10T09:40:04Z", "timestamp": 1081590004000}, "page": "59", "source": "Crossref", "is-referenced-by-count": 0, "title": ["227 Baseline prostate volume and serum PSA as predictors of prostate growth in men with benign prostatic hyperplasia"], "prefix": "10.1016", "volume": "3", "author": [{"given": "C.", "family": "Roehrborn", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["European Urology Supplements"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S156990560490228X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S156990560490228X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 14]], "date-time": "2019-02-14T06:22:38Z", "timestamp": 1550125358000}, "score": 47.321617, "issued": {"date-parts": [[2004, 2]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2004, 2]]}, "issue": "2"}, "alternative-id": ["S156990560490228X"], "URL": "http://dx.doi.org/10.1016/s1569-9056(04)90228-x", "ISSN": ["1569-9056"], "issn-type": [{"value": "1569-9056", "type": "print"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}